This exciting news was reported in the New York Post published on March 27, 2013.

Researchers might have found the Holy Grail in the war against cancer, a miracle drug that has killed every kind of cancer tumor it has come in contact with, the New York Post reported.

The drug works by blocking a protein called CD47 that is essentially a “do not eat” signal to the body’s immune system, according to Science Magazine.

Survivor. When mice with human tumors received doses of anti-CD47, which sets the immune system against tumor cells, the cancers shrank and disappeared.
Credit: Fotosearch

This protein is produced in healthy blood cells, but researchers at Stanford University found that cancer cells produced an inordinate amount of the protein thus tricking the immune system into not destroying the harmful cells.

With this observation in mind, the researchers built an antibody that blocked cancer’s CD47 so that the body’s immune system attacked the dangerous cells.

The conclusion of surveys depict that the reason of not opting for any treatment is connected with their hesitation they feel regencygrandenursing.com purchase levitra online while visiting a healthcare provider. If we feel like we lowest price on cialis regencygrandenursing.com have been cursed, we need to sit and pray. Based on the information, a couple is taken into account infertile if they are unable to give birth experience nine months – or more than a levitra generika year if they breast feed – during which it is impossible to confirm the effect of psychological component on ED suffered by a man. They generic levitra india might feel like they are secretly being laughed at and that is why cannot discuss their sexual problems openly. So far, researchers have used the antibody in mice with human breast, ovary, colon, bladder, brain, liver and prostate tumors transplanted into them. In each of the cases the antibody forced the mice’s immune system to kill the cancer cells.

“We showed that even after the tumor has taken hold, the antibody can either cure the tumor or slow its growth and prevent metastasis,” said biologist Irving Weissman of the Stanford University School of Medicine in Palo Alto, California.

One side effect of the treatment was that healthy cells were subjected to short-term attacks by the mice’s immune system, but the effect was nothing in comparison to the damage done to the cancer cells.

Weissman’s group recently received a $20 million dollar grant to move their research from mouse to human safety testing.
Read more in Science Magazine

http://http://news.sciencemag.org/sciencenow/2012/03/one-drug-to-shrink-all-tumors.html?ref=hp